I48.4 Insurance Policy Changes

ICD-10 I48.4 is officially defined as "Atypical atrial flutter." code I48.4 is referenced in 9 tracked payer policy changes from Aetna, Blue Cross & Blue Shield of Mississippi, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code I48.4 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Oct 2, 2026Medium impact
Cardiac Catheter Ablation (CPB 0165, reviewed 2026-08-25)
Aetna considers cardiac catheter ablation with electrophysiological studies medically necessary for listed atrial fibrillation, atrioventricular nodal reentrant tachycardia, atrial tachycardia and flutter, accessory pathway, and ventricular arrhythmia indications, each with its own clinical conditions such as symptoms, drug failure or intolerance, or a high-risk accessory pathway. Pulsed field ablation is considered an equally acceptable alternative to standard radiofrequency ablation for medically necessary indications. Ablation for all other indications is considered experimental, investigational, or unproven, and so are alcohol ablation of the vein of Marshall, the AtriCure Isolator Synergy EnCompass Clamp, cardio-neuro-ablation, intra-myocardial infusion-needle catheter ablation for ventricular tachycardia, non-invasive cardiac radio-ablation, and sinus node-sparing hybrid ablation.
Aetna · Identified Aug 15, 2026Medium impact
Cardiac Catheter Ablation (CPB 0165)
Aetna considers catheter ablation with electrophysiological studies medically necessary for atrial fibrillation, AVNRT, atrial tachycardia and atrial flutter, accessory pathways, and ventricular arrhythmias when the listed criteria are met, such as symptomatic AF when antiarrhythmic drugs have been ineffective, contraindicated, not tolerated or not preferred. Aetna considers catheter ablation for all other indications experimental, investigational or unproven. The policy also lists alcohol ablation of the vein of Marshall, the AtriCure Isolator Synergy EnCompass Clamp, cardio-neuro-ablation for carotid sinus hypersensitivity syncope, intra-myocardial infusion-needle catheter ablation for ventricular tachycardia, non-invasive cardiac radio-ablation, and sinus node-sparing hybrid ablation as experimental, investigational or unproven. Pulsed field ablation is considered an equally acceptable alternative to standard radiofrequency ablation for medically necessary indications.
Aetna · Identified Aug 14, 2026Medium impact
Prothrombin Time (INR) Home Testing Devices (CPB 0173, reviewed 2026-03-20)
Aetna clinical policy bulletin 0173 considers prothrombin time (INR) home testing units medically necessary durable medical equipment for patients on chronic warfarin for a mechanical heart valve, ventricular assist device, chronic atrial fibrillation, deep venous thrombosis, pulmonary embolism, venous embolism and thrombosis of deep vessels of the lower extremity, or hypercoagulable states, when the expected need for home INR testing is 6 or more months, the patient has been anticoagulated for at least 3 months before using the device, and self-testing does not occur more than once a week. Aetna considers the units experimental, investigational, or unproven for all other indications, including arterial embolism to the eye, atrial flutter, and Kawasaki disease.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures)
BCBSMS considers the maze or modified maze procedure, performed on a non-beating heart during cardiopulmonary bypass with concomitant cardiac surgery, medically necessary for the treatment of symptomatic atrial fibrillation or flutter. Stand-alone minimally invasive, off-pump maze procedures, including those done via mini-thoracotomy, are considered investigational, as is hybrid ablation (a combined percutaneous and thoracoscopic approach). An open maze or modified maze performed on a non-beating heart during cardiopulmonary bypass without concomitant cardiac surgery is also considered investigational.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Catheter Ablation as Treatment for Atrial Fibrillation
Transcatheter radiofrequency ablation, cryoablation or pulsed field ablation for atrial fibrillation may be considered medically necessary for symptomatic paroxysmal or symptomatic persistent atrial fibrillation that has failed to respond to adequate trials of antiarrhythmic medications, or as an alternative to atrioventricular nodal ablation and pacemaker insertion in individuals with class II or III congestive heart failure and symptomatic atrial fibrillation. It may also be considered medically necessary as an initial treatment for recurrent symptomatic paroxysmal atrial fibrillation (more than 1 episode, with 4 or fewer episodes in the previous 6 months) when a rhythm-control strategy is desired, and repeat ablation may be considered for recurrence of atrial fibrillation or development of atrial flutter following the initial procedure. Ablation for atrial fibrillation that does not meet these criteria is considered investigational.
Independence Blue Cross · Effective Apr 1, 2026Low impact
MA08.021c, Dofetilide (Tikosyn®) Use in the Inpatient Setting
This is a reissue with no substantive changes to Independence Blue Cross Medicare Advantage policy MA08.021c regarding dofetilide (Tikosyn®) coverage in inpatient settings. The policy maintains existing coverage criteria for AF/AFL conversion and maintenance therapy, with required 3-day minimum inpatient stay and continuous ECG monitoring. No billing workflow changes are required.
Independence Blue Cross · Effective Apr 1, 2026Low impact
08.00.49f, Dofetilide (Tikosyn®) Use in the Inpatient Setting
Independence Blue Cross reissued policy 08.00.49f with no substantive changes to dofetilide (Tikosyn®) coverage for inpatient use. The policy maintains coverage for AF/AFL conversion and NSR maintenance when initiated/escalated/reinitiated in an inpatient setting with continuous ECG monitoring for minimum 3 days, and continues to exclude paroxysmal AF as not medically necessary.
Independence Blue Cross · Identified Jun 19, 2026Low impact
MA11.060h, Catheter Ablation of Cardiac Arrhythmias
Independence Blue Cross reissued Medical Policy MA11.060h on 06/10/2026 as part of their annual review process with no substantive coverage changes. CPT code 93656 narrative was revised effective 01/01/2025 due to annual CPT code updates. The policy continues to cover catheter ablation for supraventricular and ventricular arrhythmias under specified medical necessity criteria for Medicare Advantage members.
Independence Blue Cross · Identified Jun 19, 2026Low impact
MA11.060h, Catheter Ablation of Cardiac Arrhythmias
Independence Blue Cross reissued MA11.060h (now superseded by MA11.060i) as part of their annual review process on 06/10/2026. This is a routine policy reissuance with no substantive changes to coverage criteria for catheter ablation of cardiac arrhythmias. A CPT code update (93656) was processed effective 01/01/2025, but the policy itself maintains existing coverage requirements for supraventricular and ventricular arrhythmias.

Watch I48.4

Get one email when a payer policy names I48.4, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code I48.4?

There are 9 tracked policy changes affecting code I48.4, including updates from Aetna, Blue Cross & Blue Shield of Mississippi, Independence Blue Cross. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code I48.4?

Payers that have issued tracked updates for code I48.4 include: Aetna, Blue Cross & Blue Shield of Mississippi, Independence Blue Cross.

How do I get notified when code I48.4 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code I48.4. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code I48.4?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Cardiac Catheter Ablation (CPB 0165, reviewed 2026-08-25)

Cardiac Catheter Ablation (CPB 0165)

Prothrombin Time (INR) Home Testing Devices (CPB 0173, reviewed 2026-03-20)

Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures)

Catheter Ablation as Treatment for Atrial Fibrillation

MA08.021c, Dofetilide (Tikosyn®) Use in the Inpatient Setting

08.00.49f, Dofetilide (Tikosyn®) Use in the Inpatient Setting

MA11.060h, Catheter Ablation of Cardiac Arrhythmias

MA11.060h, Catheter Ablation of Cardiac Arrhythmias

What insurance policy changes affect code I48.4?

Which payers have updated policy for code I48.4?

How do I get notified when code I48.4 policy changes?

Why do payers change policies for code I48.4?